954124-08-4Relevant academic research and scientific papers
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
-
Page/Page column 26, (2009/05/28)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
NK-1 AND SEROTONIN TRANSPORTER INHIBITORS
-
Page/Page column 76, (2010/11/28)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both.
